4//SEC Filing
Price David 4
Accession 0001209191-09-043318
CIK 0001145404other
Filed
Sep 2, 8:00 PM ET
Accepted
Sep 3, 5:16 PM ET
Size
7.2 KB
Accession
0001209191-09-043318
Insider Transaction Report
Form 4
Price David
Chief Financial Officer
Transactions
- Sale
Common Stock
2009-09-01$7.00/sh−38,000$266,000→ 287,133 total - Sale
Common Stock
2009-09-03$7.06/sh−112,000$791,235→ 175,133 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.00 to $7.15, inclusive. The reporting person undertakes to provide to Cornerstone Therapeutics Inc., any security holder of Cornerstone Therapeutics Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
Documents
Issuer
CORNERSTONE THERAPEUTICS INC
CIK 0001145404
Entity typeother
Related Parties
1- filerCIK 0001449336
Filing Metadata
- Form type
- 4
- Filed
- Sep 2, 8:00 PM ET
- Accepted
- Sep 3, 5:16 PM ET
- Size
- 7.2 KB